Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2019

Summary of Significant Accounting Policies

Schedule of disaggregation of revenue by major source

The following table disaggregates our revenues by major source for the years ended December 31, 2019 and 2018:

	December 31,
(000’s omitted)	2019		2018
Global Logistics Solutions:
Biopharmaceutical	$	27,003	$	16,477
Reproductive Medicine		2,914		2,173
Animal Health		996		976
Total Global Logistics Solutions		30,913		19,626
Global Bioservices		3,029		—
Total revenues	$	33,942	$	19,626

Schedule of geographical revenues, by origin

Our geographical revenues, by origin, for the years ended December 31, 2019 and 2018, were as follows:

	December 31,
(000’s omitted)	2019		2018
Americas	$	28,801	$	17,877
Europe, the Middle East and Africa (EMEA)		4,523		1,365
Asia Pacific (APAC)		618		384
Total revenues	$	33,942	$	19,626

Schedule of net loss per share

The following shows the amounts used in computing net loss per share:

	Years Ended December 31,
	2019		2018
Net loss	$	(18,331,479)	$	(9,555,601)
Weighted average common shares outstanding – basic and diluted		33,394,285		28,210,648
Basic and diluted net loss per share	$	(0.55)	$	(0.34)

Schedule of number of shares excluded from the computation of diluted loss per share

The following table sets forth the number of shares excluded from the computation of diluted loss per share, as their inclusion would have been anti-dilutive:

	Years Ended December 31,
	2019	2018
Stock Options	3,636,806	3,130,635
Warrants	753,211	1,329,594
Convertible Note	—	1,372,998
	4,390,017	5,833,227